HARVARD BIOSCIENCE, INC. Net Income (Loss) Available to Common Stockholders, Basic
HARVARD BIOSCIENCE, INC. (HBIO) reported Net Income (Loss) Available to Common Stockholders, Basic of -$1.24 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2023-11-07
- HARVARD BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2023-09-30 was -$1.24M.
- HARVARD BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2023-06-30 was -$980.00K, a 140.25% decline year-over-year.
- HARVARD BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2022-09-30 was -$3.40M.
- HARVARD BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2022-06-30 was $2.44M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month |
|---|---|---|---|
| 2023-09-30 | -$1.24M 10-Q · filed 2023-11-07 | -$2.22M derived: sum of 2 quarters · filed 2023-11-07 | -$1.60M 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$980.00K 10-Q · filed 2023-08-08 | -$358.00K 10-Q · filed 2023-08-08 | |
| 2022-09-30 | -$3.40M 10-Q · filed 2023-11-07 | -$970.00K derived: sum of 2 quarters · filed 2023-11-07 | -$7.85M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $2.44M 10-Q · filed 2023-08-08 | -$4.45M 10-Q · filed 2023-08-08 | |
| 2021-09-30 | -$170.00K 10-Q · filed 2022-11-09 | -$1.25M 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |